跳至主要内容
临床试验/IRCT20180922041089N2
IRCT20180922041089N2招募中3 期

The Study of Vitamin D supplementation`s effect in the treatment of Helicobacter pylori eradication in patients with dyspepsia

Tehran University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age over 18 years
  • A test of the fecal antigen of the Helicobacter pylori or Rapid urease test (RUT) is positive
  • All patients with functional dyspepsia of the pseudo-ulcer type who did not respond to (or recurring) acid reflux therapy, or the presence or history of gastric or duodenal peptic ulcer in a patient or first-degree relatives of patients with gastric cancer
  • Informed consent Form

排除标准

  • The history of epilepsy
  • History of chronic diseases (CHB, CKD, COPD, recurrent CVA or dementia, liver cirrhosis)
  • Patients own cancers
  • Severe psychiatric illnesses such as schizophrenia, major depression, bipolar disorders
  • History of antibiotic use in the last 6 weeks
  • Patients with dyspepsia with a predominant symptom of reflux
  • Drug, alcohol and cigarettes
  • History of gastric surgeries, IBD, diabetes, pathological weight loss (weight loss over 10% of body weight over the past 6 months)
  • Anemia (Hemoglobin in men under 14 in males under 11 and in menopausal women under 12 (1))
  • Diabetes (if FBS is greater than or equal to 126 or HbA1c greater than or equal to 6.5%)
  • corticosteroids use in the last 3 months
  • Use of vitamin D supplements with therapeutic doses during the last 3 months or during the study
  • Participate in another research project over the past 3 months
  • Pregnancy or breastfeeding
  • History of H pylori infection treatment in the past
  • History of kidney stones
  • Participants' unwillingness to take medication or placebo
  • History of any allergy or side effects
  • BMI greater than 40

研究者

相似试验

The Study of Vitamin D Supplement-aid in the... | 临床试验